Boston scientific exercises option to acquire farapulse, inc.

Marlborough, mass., june 24, 2021 /prnewswire/ -- boston scientific corporation (nyse: bsx) today announced it exercised its option to acquire the remaining shares of farapulse, inc. the acquisition will complement the existing boston scientific electrophysiology portfolio to include the farapulse pulsed field ablation (pfa) system – a non-thermal ablation system for the treatment of atrial fibrillation (af) and other cardiac arrhythmias.
BSX Ratings Summary
BSX Quant Ranking